269 related articles for article (PubMed ID: 18767405)
1. Understanding the genetic causes of inter-patient variability. Clinical relevance with focus on cardiovascular drugs.
Ginghină C; Stănescu R; Coman IM; Bărbari L; Popescu BA
Rom J Intern Med; 2007; 45(4):313-9. PubMed ID: 18767405
[TBL] [Abstract][Full Text] [Related]
2. Enzymes and pharmacogenetics of cardiovascular drugs.
Siest G; Jeannesson E; Visvikis-Siest S
Clin Chim Acta; 2007 May; 381(1):26-31. PubMed ID: 17362901
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
4. Role of CYP pharmacogenetics and drug-drug interactions in the efficacy and safety of atypical and other antipsychotic agents.
Murray M
J Pharm Pharmacol; 2006 Jul; 58(7):871-85. PubMed ID: 16805946
[TBL] [Abstract][Full Text] [Related]
5. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.
Ingelman-Sundberg M; Sim SC; Gomez A; Rodriguez-Antona C
Pharmacol Ther; 2007 Dec; 116(3):496-526. PubMed ID: 18001838
[TBL] [Abstract][Full Text] [Related]
6. [Individualized pharmacotherapy based on cytochrome P-450 (CYP) genotyping].
Johansen PW; Bergan S; Rootwelt H; Kvittingen EA; Rugstad HE
Tidsskr Nor Laegeforen; 2002 Nov; 122(29):2781-3. PubMed ID: 12523145
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics-guided dose modifications of antidepressants.
Seeringer A; Kirchheiner J
Clin Lab Med; 2008 Dec; 28(4):619-26. PubMed ID: 19059066
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics of cytochrome P450 (CYP) in the elderly.
Seripa D; Pilotto A; Panza F; Matera MG; Pilotto A
Ageing Res Rev; 2010 Oct; 9(4):457-74. PubMed ID: 20601196
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics in HIV therapy.
Rodríguez-Nóvoa S; Barreiro P; Jiménez-Nacher I; Rendón A; Soriano V
AIDS Rev; 2005; 7(2):103-12. PubMed ID: 16092504
[TBL] [Abstract][Full Text] [Related]
10. Polymorphic cytochrome P450 enzymes and post-marketing drug dosage revisions: clinical relevance to dermatologic therapies.
Saggar S; Maibach HI
Cutan Ocul Toxicol; 2007; 26(3):171-80. PubMed ID: 17687682
[TBL] [Abstract][Full Text] [Related]
11. Probing the world of cytochrome P450 enzymes.
Frye RF
Mol Interv; 2004 Jun; 4(3):157-62. PubMed ID: 15210869
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacogenomics: the quest for individualized therapy].
López-López M; Guerrero-Camacho JL; Familiar-López IM; Jung-Cook H; Corona-Vázquez T; Alonso-Vilatela ME
Rev Neurol; 2004 Dec 1-15; 39(11):1063-71. PubMed ID: 15597270
[TBL] [Abstract][Full Text] [Related]
13. Updates on cytochrome P450-mediated cardiovascular drug interactions.
Cheng JW; Frishman WH; Aronow WS
Am J Ther; 2009; 16(2):155-63. PubMed ID: 19114873
[TBL] [Abstract][Full Text] [Related]
14. Cytochromes P450: decision-making tools for personalized therapeutics.
Murray M; Petrovic N
Curr Opin Mol Ther; 2006 Dec; 8(6):480-6. PubMed ID: 17243482
[TBL] [Abstract][Full Text] [Related]
15. [Genetic polymorphism of the metabolism of drugs used in cardiac diseases].
Funck-Brentano C
Arch Mal Coeur Vaiss; 1991 Sep; 84(9):1353-9. PubMed ID: 1683530
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenomics and cardiovascular drugs: need for integrated biological system with phenotypes and proteomic markers.
Siest G; Marteau JB; Maumus S; Berrahmoune H; Jeannesson E; Samara A; Batt AM; Visvikis-Siest S
Eur J Pharmacol; 2005 Dec; 527(1-3):1-22. PubMed ID: 16316654
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 enzymes and the heart.
Chaudhary KR; Batchu SN; Seubert JM
IUBMB Life; 2009 Oct; 61(10):954-60. PubMed ID: 19787709
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacogenetics--new perspectives in the treatment of cardiovascular diseases].
Dzida G
Kardiol Pol; 2004 Mar; 60(3):304-8. PubMed ID: 15156230
[No Abstract] [Full Text] [Related]
19. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
Lynch T; Price A
Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
[TBL] [Abstract][Full Text] [Related]
20. Genetic testing for pharmacogenetics and its clinical application in drug therapy.
Hiratsuka M; Sasaki T; Mizugaki M
Clin Chim Acta; 2006 Jan; 363(1-2):177-86. PubMed ID: 16126184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
